Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune, inflammatory disease of the central nervous system (CNS), which causes damage to myelin and axons, resulting in neurological symptoms such as partial loss of sight, paresthesias and ataxia.
Multiple Sclerosis Products Targets
- STAT (10)
- Voltage-gated Potassium (KV) Channel (38)
- Integrin Receptor (15)
- Others (29)
- Complement (2)
- Vitamin D Receptor (10)
- PORCN (4)
- beta-catenin (13)
- Casein Kinase 1 (7)
- AMPA Receptor (45)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- NMDA Receptor (87)
- Kainate Receptor (22)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- TRPM (8)
- Tankyrase (5)
- ROS and Other Gaseous Donor (8)
- Nrf2 (5)
- ITK (2)
- ASK1 (2)
- Acid-Sensing Ion Channel (3)
- Calcium-Activated Potassium (KCa) Channel (19)
- Inward Rectifier Potassium (Kir) Channel (21)
- NCX (5)
- Retinoid X Receptor (13)
- Cytokine (15)
Products for Multiple Sclerosis - Page 27
- Cat.No. Product Name Information/Activity
-
BCC7789
NPEC-caged-(S)-AMPA
1257323-84-4
-
BCC6568
L-Quisqualic acid
52809-07-1
-
BCC6931
CFM-2
CFM-2 is a selective non-competitive AMPAR antagonist.
-
BCC6569
CNQX
CNQX (FG9065) is a potent AMPA/kainate receptor antagonist.
-
BCC6908
CNQX disodium salt
479347-85-8
-
BCC7520
CP 465022 hydrochloride
199655-36-2
-
BCC6815
Evans Blue tetrasodium salt
Selective P2X purinergic antagonist,Evans Blue is a potent inhibitor of L-glutamate uptake via the membrane bound excitatory amino acid transporter (EAAT).
-
BCC7566
GYKI 47261 dihydrochloride
1217049-32-5
-
BCC7072
GYKI 52466 dihydrochloride
102771-26-6
-
BCC7407
GYKI 53655 hydrochloride
GYKI53655 hydrochloride is an α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) antagonist.
